Fenoldopam Intravenous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fenoldopam Intravenous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fenoldopam
Brand name: Corlopam
Synonyms: Fenoldopam
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fenoldopam Intravenous-Insulin degludec
- Fenoldopam Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Fenoldopam Intravenous-Insulin Degludec (U-100) Vials
- Fenoldopam Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Fenoldopam Intravenous-Insulin degludec and liraglutide
- Fenoldopam Intravenous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fenoprofen
- Insulin aspart, recombinant Subcutaneous-Fenoprofen Calcium
- Insulin aspart, recombinant Subcutaneous-Fenoprofen Capsules
- Insulin aspart, recombinant Subcutaneous-Fenortho
- Insulin aspart, recombinant Subcutaneous-Fentanyl
- Insulin aspart, recombinant Subcutaneous-Fentanyl Buccal mucosa, Oromucosal